New research reveals flu drugs like Tamiflu might help combat cognitive decline and premature aging in people with HIV by protecting key sugar molecules called glycans that shield the body from harmful inflammation. Scientists found these glycans break down in HIV patients, contributing to brain issues—even on treatment. The drugs block the enzyme causing this breakdown, offering a promising, early proof of concept. But experts warn against self-medication and stress the need for more studies to confirm safety, dosage, and potential for new targeted therapies. The ultimate goal? Extend not just lifespan, but healthspan—ensuring people with HIV live longer, healthier, more fulfilling lives.
Support the show: Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
